Drug class
Cardiac glycoside; cardiotonic and antiarrhythmic agent
Mechanism of action
Inhibits myocardial Na+/K+-ATPase, increasing intracellular sodium and indirectly increasing intracellular calcium through reduced sodium-calcium exchange. This increases myocardial contractility and also enhances vagal tone, slowing atrioventricular conduction. Metildigoxin is demethylated to digoxin.
General use cases
- Historical and jurisdiction-specific use for symptomatic treatment of selected cases of chronic heart failure and supraventricular arrhythmias, including atrial fibrillation; product availability and current use vary by country.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
